Article Data

  • Views 1358
  • Dowloads 143

Original Research

Open Access

Comparison of clinical efficacy and safety between intravenous thrombolysis and endovascular therapy in patients with acute large vessel occlusion stroke of the posterior circulation

  • Jianmei Cai1
  • Guangjun Xi1
  • Zheng Dai1,*,

1Department of Neurology, the Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, 214023 Wuxi, Jiangsu, China

DOI: 10.22514/sv.2023.055 Vol.19,Issue 4,July 2023 pp.129-134

Submitted: 23 November 2022 Accepted: 04 January 2023

Published: 08 July 2023

*Corresponding Author(s): Zheng Dai E-mail: zheng_d1121@163.com

Abstract

To investigate the efficacy and safety of intravenous thrombolytic (IVT) therapy and endovascular (EV) therapy in patients with acute posterior large vessel occlusion stroke (PLVOS). A total of fifty patients with acute PLVOS were randomly divided into the IVT group and EV group. The general baseline data, post-treatment vascular recanalization rate, National Institute of Health Stroke Scale (NIHSS) score before and after intervention, prognosis, and perioperative complications were compared between the two groups. There were no significant differences in the overall baseline data between the two groups (p > 0.05). The post-treatment recanalization rate was significantly higher in the EV group (88.00%) than in the IVT group (64.00%, p < 0.05). The NIHSS score at 24 h post-admission was significantly lower and prognosis was significantly better in the EV group than in the IVT group (both p < 0.05). The EV group had significantly lower overall complication rate (16.00%) than the IVT group (48.00%, p < 0.05). Compared with IVT therapy, EV therapy can effectively improve neurological damage, vascular recanalization rate and prognosis as well as reduce the incidence of perioperative complications in patients with acute PLVOS.


Keywords

Acute posterior large vessel occlusion stroke; Intravenous thrombolytic therapy; Endovascular therapy; Recanalization rate; Safety evaluation


Cite and Share

Jianmei Cai,Guangjun Xi,Zheng Dai. Comparison of clinical efficacy and safety between intravenous thrombolysis and endovascular therapy in patients with acute large vessel occlusion stroke of the posterior circulation. Signa Vitae. 2023. 19(4);129-134.

References

[1] Rabinstein AA. Update on treatment of acute ischemic stroke. Contin-uum. 2020; 26: 268–286.

[2] Maida CD, Norrito RL, Daidone M, Tuttolomondo A, Pinto A. Neu-roinflammatory mechanisms in ischemic stroke: focus on cardioembolic stroke, background, and therapeutic approaches. International Journal of Molecular Sciences. 2020; 21: 6454.

[3] Silva GS, Nogueira RG. Endovascular treatment of acute ischemic stroke. Continuum. 2020; 26: 310–331.

[4] Jolugbo P, Ariëns RAS. Thrombus composition and efficacy of thrombolysis and thrombectomy in acute ischemic stroke. Stroke. 2021; 52: 1131–1142.

[5] Ajoolabady A, Wang S, Kroemer G, Penninger JM, Uversky VN, Pratico D, et al. Targeting autophagy in ischemic stroke: from molecular mechanisms to clinical therapeutics. Pharmacology & Therapeutics. 2021; 225: 107848.

[6] Datta A, Sarmah D, Mounica L, Kaur H, Kesharwani R, Verma G, et al. Cell death pathways in ischemic stroke and targeted pharmacotherapy. Translational Stroke Research. 2020; 11: 1185–1202.

[7] Mendelson SJ, Prabhakaran S. Diagnosis and management of transient ischemic attack and acute ischemic stroke: a review. JAMA. 2021; 325: 1088–1098.

[8] Warach SJ, Dula AN, Milling TJ Jr. Tenecteplase thrombolysis for acute ischemic stroke. Stroke. 2020; 51: 3440–3451.

[9] Li L, Cheng P, Zhang J, Wang G, Hu T, Sun F. Clinical effect and prognostic factors of mechanical thrombectomy in the treatment of acute ischemic stroke. Pakistan Journal of Medical Sciences. 2022; 38: 1107–1112.

[10] Pan L, Jin J, Huang R, Wang W, Chen Q. Application of transcranial Doppler in prognosis assessment of nerve function in patients with acute cerebral infarction after intracranial mechanical thrombectomy. Chinese Critical Care Medicine. 2020; 32: 835–839.

[11] Sinha D, Nag P, Nanayakkara D, Duijf PHG, Burgess A, Raninga P, et al. Cep55 overexpression promotes genomic instability and tumorigenesis in mice. Communications Biology. 2020; 3: 593.

[12] Pirson FAVA, Boodt N, Brouwer J, Bruggeman AAE, Hinsenveld WH, Staals J, et al. Etiology of large vessel occlusion posterior circulation stroke: results of the MR CLEAN registry. Stroke. 2022; 53: 2468–2477.

[13] Sweid A, Hammoud B, Ramesh S, Wong D, Alexander TD, Weinberg JH, et al. Acute ischaemic stroke interventions: large vessel occlusion and beyond. Stroke and Vascular Neurology. 2020; 5: 80–85.

[14] Roaldsen MB, Lindekleiv H, Mathiesen EB. Intravenous thrombolytic treatment and endovascular thrombectomy for ischaemic wake-up stroke. Cochrane Database of Systematic Reviews. 2021; 12: CD010995.

[15] Turc G, Tsivgoulis G, Audebert HJ, Boogaarts H, Bhogal P, De Marchis GM, et al. European stroke organisation (ESO)—European society for minimally invasive neurological therapy (ESMINT) expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischemic stroke and anterior circulation large vessel occlusion. Journal of NeuroInterventional Surgery. 2022; 14: 209–227.

[16] Lattanzi S, Coccia M, Pulcini A, Cagnetti C, Galli FL, Villani L, et al. Endovascular treatment and cognitive outcome after anterior circulation ischemic stroke. Scientific Reports. 2020; 10: 18524.

[17] Jovin TG, Nogueira RG, Lansberg MG, Demchuk AM, Martins SO, Mocco J, et al. Thrombectomy for anterior circulation stroke beyond 6 h from time last known well (AURORA): a systematic review and individual patient data meta-analysis. The Lancet. 2022; 399: 249–258.

[18] Mullen MT, Pisapia JM, Tilwa S, Messé SR, Stein SC. Systematic review of outcome after ischemic stroke due to anterior circulation occlusion treated with intravenous, intra-arterial, or combined intravenous + intra-arterial thrombolysis. Stroke. 2012; 43: 2350–2355.

[19] Jadhav AP, Desai SM, Jovin TG. Indications for mechanical thrombectomy for acute ischemic stroke: current guidelines and beyond. Neurology. 2021; 97: S126–S136.

[20] Zhang Y, Shi M, Wang Z, Li C, Sun M, Zhou J, et al. Factors associated with poor outcomes in patients undergoing endovascular therapy for acute ischemic stroke due to large-vessel occlusion in acute anterior circulation: a retrospective study. World Neurosurgery. 2021; 149: e128–e134.

[21] Ganesh A, Ospel JM, Menon BK, Demchuk AM, McTaggart RA, Nogueira RG, et al.; ESCAPE-NA1 trial investigators. assessment of discrepancies between follow-up infarct volume and 90-day outcomes among patients with ischemic stroke who received endovascular therapy. JAMA Network Open. 2021; 4: e2132376.

[22] Zi W, Qiu Z, Li F, Sang H, Wu D, Luo W, et al. Effect of endovascular treatment alone vs intravenous alteplase plus endovascular treatment on functional independence in patients with acute ischemic stroke: the DEVT randomized clinical trial. JAMA. 2021; 325: 234–243.

[23] Hasan TF, Hasan H, Kelley RE. Overview of acute ischemic stroke evaluation and management. Biomedicines. 2021; 9: 1486.

[24] Treurniet KM, LeCouffe NE, Kappelhof M, Emmer BJ, van Es ACGM, Boiten J, et al.; MR CLEAN-NO IV Investigators. MR CLEAN-NO IV: intravenous treatment followed by endovascular treatment versus direct endovascular treatment for acute ischemic stroke caused by a proximal intracranial occlusion-study protocol for a randomized clinical trial. Trials. 2021; 22: 141.

[25] Hartmann C, Winzer S, Pallesen L, Prakapenia A, Siepmann T, Moustafa H, et al. Inadvertent hypothermia after endovascular therapy is not associated with improved outcome in stroke due to anterior circulation large vessel occlusion. European Journal of Neurology. 2021; 28: 2479–2487.

[26] Liu X, Dai Q, Ye R, Zi W, Liu Y, Wang H, et al.; BEST Trial Investigators. Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. The Lancet Neurology. 2020; 19: 115–122.

[27] Writing Group for the BASILAR Group; Zi W, Qiu Z, Wu D, Li F, Liu H, Liu W, et al. Assessment of endovascular treatment for acute basilar artery occlusion via a nationwide prospective registry. JAMA Neurology. 2020; 77: 561–573.

[28] Alexandre AM, Valente I, Consoli A, Piano M, Renieri L, Gabrieli JD, et al. Posterior circulation endovascular thrombectomy for large-vessel occlusion: predictors of favorable clinical outcome and analysis of first-pass effect. American Journal of Neuroradiology. 2021; 42: 896–903.

[29] Chalos V, van der Ende NAM, Lingsma HF, Mulder MJHL, Venema E, Dijkland SA, et al.; MR CLEAN Investigators. National institutes of health stroke scale: an alternative primary outcome measure for trials of acute treatment for ischemic stroke. Stroke. 2020; 51: 282–290.

[30] Yamal JM, Grotta JC. National institutes of health stroke scale as an outcome measure for acute stroke trials. Stroke. 2021; 52: 142–143.


Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 1.0 (2022) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time

Conferences

Top